Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma

about

Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma

Item

http://www.wikidata.org/entity/Q58763031

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 05 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Clinical Characteristics and e ...... osing epithelioid fibrosarcoma

@en

Clinical Characteristics and e ...... osing epithelioid fibrosarcoma

@nl

type

Item

label

Clinical Characteristics and e ...... osing epithelioid fibrosarcoma

@en

Clinical Characteristics and e ...... osing epithelioid fibrosarcoma

@nl

prefLabel

Clinical Characteristics and e ...... osing epithelioid fibrosarcoma

@en

Clinical Characteristics and e ...... osing epithelioid fibrosarcoma

@nl

P1476

Clinical Characteristics and e ...... osing epithelioid fibrosarcoma

@en

P2093

Aisha Miah

http://www.w3.org/2001/XMLSchema#string

Alex T J Lee

http://www.w3.org/2001/XMLSchema#string

Andrew Hayes

http://www.w3.org/2001/XMLSchema#string

Charlotte Benson

http://www.w3.org/2001/XMLSchema#string

Christina Messiou

http://www.w3.org/2001/XMLSchema#string

Cyril Fisher

http://www.w3.org/2001/XMLSchema#string

Khin Thway

http://www.w3.org/2001/XMLSchema#string

Shane Zaidi

http://www.w3.org/2001/XMLSchema#string

Winette T van der Graaf

http://www.w3.org/2001/XMLSchema#string

Winston Chew

http://www.w3.org/2001/XMLSchema#string

P2860

Sclerosing epithelioid fibrosarcoma of the bone: a case report of high resistance to chemotherapy and a survey of the literature

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.

Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor.

Multiple bone metastasis of sclerosing epithelioid fibrosarcoma 12 years after initial surgery-increasing ki-67 labeling index.

Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma.

In-depth genetic analysis of sclerosing epithelioid fibrosarcoma reveals recurrent genomic alterations and potential treatment targets.

The hundredth case of sclerosing epithelioid fibrosarcoma (SEF).

Primary sclerosing epithelioid fibrosarcoma of bone: analysis of a series.

MUC4 Is a Sensitive and Extremely Useful Marker for Sclerosing Epithelioid Fibrosarcoma

P2888

s12032-018-1192-6

P304

138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-018-1192-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robin L Jones

P577

2018-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30187231

http://www.w3.org/2001/XMLSchema#string

P921

hematology

cancer research

chemotherapy

P932

6132781

http://www.w3.org/2001/XMLSchema#string